Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Holders of 5% or more of IMNM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Immunome Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%13.1M shares | +7.90 ppfrom 7.10% | May 12, 20253 filings | Oct 7, 2025 | SEC |
| T. Rowe Price Investment Management, Inc. | 13G | 12.20%10.6M shares | New | Nov 7, 20251 filing | Nov 7, 2025 | SEC |
| Redmile Group, LLC | 13G/A | 6.20%5.36M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |
| Immunome Aggregator, LP | 13D/A | 6.00%4.77M shares | – | Feb 4, 20251 filing | Feb 4, 2025 | SEC |
| Point72 Asset Management, L.P. | 13G | 5.90%4.89M shares | New | Feb 3, 20251 filing | Feb 3, 2025 | SEC |
| Vanguard Group Inc | 13G | 5.20%4.52M shares | +0.39 ppfrom 4.81% | Jan 30, 20252 filings | Jul 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Immunome Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 22, 20259:22 PM ET | Enavate Sciences GP, LLCand 1 other | 13D/A | 4.30%4.77M shares | –Below 5% | Dec 18, 2025 | SEC |
| Nov 7, 20251:02 PM ET | T. Rowe Price Investment Management, Inc. | 13G | 12.20%10.6M shares | New | Oct 31, 2025 | SEC |
| Oct 7, 20253:49 PM ET | FMR LLCand 1 other | 13G/A | 15.00%13.1M shares | +7.90 ppfrom 7.10% | Sep 30, 2025 | SEC |
| Aug 6, 202512:06 PM ET | FMR LLCand 1 other | 13G | 7.10%6.17M shares | +2.60 ppfrom 4.50% | Jun 30, 2025 | SEC |
| Jul 29, 20251:00 PM ET | Vanguard Group Inc | 13G | 5.20%4.52M shares | +0.39 ppfrom 4.81% | Jun 30, 2025 | SEC |
| May 15, 20259:01 PM ET | Redmile Group, LLCand 2 others | 13G/A | 6.20%5.36M shares | – | Mar 31, 2025 | SEC |
| May 15, 20252:04 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 4.70%4.08M shares | –Below 5% | Mar 31, 2025 | SEC |
| May 14, 202510:40 AM ET | Janus Henderson Group PLC | 13G/A | 2.20%1.91M shares | −3.30 ppfrom 5.50%Below 5% | Mar 31, 2025 | SEC |
| May 12, 202510:32 AM ET | FMR LLCand 1 other | 13G/A | 4.50%3.89M shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 202512:35 PM ET | Janus Henderson Group PLC | 13G/A | 5.50%3.46M shares | – | Dec 31, 2024 | SEC |
| Feb 4, 20255:44 PM ET | Immunome Aggregator, LPand 1 other | 13D/A | 6.00%4.77M shares | – | Jan 31, 2025 | SEC |
| Feb 3, 20255:08 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 5.90%4.89M shares | New | Jan 31, 2025 | SEC |
| Jan 30, 20259:57 PM ET | Vanguard Group Inc | 13G/A | 4.81%3.00M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Immunome Inc. shares.
No Form 144 notices for Immunome Inc. are on file.